PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2015 | 87 | 7 | 371-374
Tytuł artykułu

Encapsulating Peritoneal Sclerosis – Rare Cause Of Bowel Obstruction

Treść / Zawartość
Warianty tytułu
Języki publikacji
EN
Abstrakty
Słowa kluczowe
Wydawca
Rocznik
Tom
87
Numer
7
Strony
371-374
Opis fizyczny
Daty
wydano
2015-07-01
otrzymano
2015-02-12
online
2015-09-07
Twórcy
autor
  • Department of General and Hand Surgery, Pomeranian Medical UniversityKierownik: prof. dr hab. , pawel_dec@onet.pl
  • Department of General Surgery, 109 Military Hospital in SzczecinKoordynator: dr n. med.
  • Department of General Surgery, 109 Military Hospital in SzczecinKoordynator: dr n. med.
  • Department of General Surgery, 109 Military Hospital in SzczecinKoordynator: dr n. med.
  • Department of Thoracic Surgery and Transplantology, Pomeranian Medical UniversityKierownik: prof. dr hab.
Bibliografia
  • 1. Ulmer C, Braun N, Rieber F et al.: Efficacy and morbidity of surgical therapy in late-stage encapsulating peritoneal sclerosis. Surgery Feb 2013; 153(2): 219-24.
  • 2. Gupta S, Shirahatti RG, Anand J: CT Findings of an Abdominal Cocoon. Am J Roentgenol 2004 Dec; 183.
  • 3. Nakayama M, Terawaki H: Multidisciplinary clinical strategies for encapsulating peritoneal sclerosis in peritoneal dialysis: Update from Japan. Int J Urol 2014; 21: 755-61.
  • 4. Habib SM, Betjes MG, Fieren MW et al.: Management of encapsulating peritoneal sclerosis: a guideline on optimal and uniform treatment. Neth J Med 2011 Nov-Dec; 69(11): 500-07.
  • 5. Lo WK, Kawanishi H: Encapsulating peritoneal sclerosis-medical and surgical treatment. Perit Dial Int 2009 Feb; 29 (Suppl 2): S211-14.
  • 6. Kawanishi H, Moriishi M, Tsuchiya S: Experience of 100 surgical cases of encapsulating peritoneal sclerosis: investigation of recurrent cases after surgery. Adv Perit Dial 2006; 22: 60-64.
  • 7. Tannoury JN, Abboud BN: Idiopathic sclerosing encapsulating peritonitis: Abdominal cocoon. World J Gastroenterol 2012 May 7; 18(17): 1999-2004.
  • 8. Li N, Zhu W, Li Y et al.: Surgical Treatment and Perioperative Management of Idiopathic Abdominal Cocoon: Single-Center Review of 65 Cases. World J Surg 2014 38: 1860-67.
  • 9. Neto P, Borges A, Oliveira HS et al.: A successful clinical case of encapsulating peritoneal sclerosis-surgical management using enterolysis. Nefrologia 2012; 32(6): 829-34.
  • 10. Naniwadekar RG, Kulkarni SR, Bane P et al.: Abdominal cocoon: an unusual presentation of small bowel obstruction. J Clin Diagn Res 2014 Feb; 8(2): 173-74.
  • 11. Upponi S, Butler AJ, Watson CJ et al.: Encapsulating peritoneal sclerosis Correlation of radiological findings at CT with underlying pathogenesis. Clin Radiol 2014; 69 103-09
  • 12. Vlijm A, Stoker J, Bipat S et al.: Computed tomographic findings characteristic for encapsulating peritoneal sclerosis: a case-control study. Perit Dial Int 2009; 29(5): 517-22.
  • 13. Braun N, Fritz P, Ulmer C et al.: Histological Criteria for Enapsulating Peritoneal Sclerosis – A Standardized Approach. PLoS One 2012; 7(11): e48647.
  • 14. Braun N, Alscher D, Fritz P et al.: Podoplanin-positive cells are a hallmark of encapsulating peritoneal sclerosis. Nephrol Dial Transplant 2011; 26: 1033-41
  • 15. Braun N, Alscher D, Fritz P et al.: The Spectrum of Podoplanin Expression in Encapsulating Peritoneal Sclerosis Sclerosis. PLoS One 2012; 7(12): e53382.
  • 16. Kawanishi H, Harada Y, Sakikubo E et al.: Surgical treatment for sclerosing encapsulating peritonitis. Adv Perit Dial 2000; 16: 252-56.
  • 17. Nakayama M: The plasma leak-to-response hypothesis: a working hypothesis on the pathogenesis of encapsulating peritoneal sclerosis after long-term peritoneal dialysis treatment. Peri Dial Int 2005; 25: S71-S76.
  • 18. Yanez-Mo M, Lara-Pezzi E, Selgas R et al.: Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. New Engl J Med 2003; 348: 403-13.
  • 19. Loureiro J, Gónzalez-Mateo G, Jimenez-Heffernan J et al.: Are the Mesothelial-to-Mesenchymal Transition, Sclerotic Peritonitis Syndromes, and Encapsulating Peritoneal Sclerosis Part of the Same Process? Int J Nephrol 2013.
  • 20. Aguilera A, Aroeira LS, Ramirez-Huesca M et al.: Effects of rapamycin on the epithelial-to-mesenchymal transition of human peritoneal mesothelial cells. Int J Artif Organs 2005; 28: 164-69.
  • 21. Hoff CM: Experimental animal models of encapsulating peritoneal sclerosis. Perit Dial Int 2005 Apr; 25 Suppl 4: S57-66.
  • 22. Saglam F, Cavdar Z, Sarioglu S et al.: Pioglitazone Reduces Peritoneal Fibrosis via Inhibition of TGF-β, mmP-2, and mmP-9 in a Model of Encapsulating Peritoneal Sclerosis. Renal Failure 2012; 34(1): 95-102
  • 23. Brands W, Diehm T, Lochbühler H: Use of fibrin glue in prevention and therapy of intraabdominal adhesions. Chirurg 1990; 61(1): 22-26.
  • 24. Dinsmore JE, Jackson RJ, Wagner CW: Management of multiple intestinal atresias and perforations with intraluminal stenting. Pediatr Surg Int 1998; 13(2-3): 226-28.
  • 25. Singh S, Gagneja HK : Stents in the small intestine. Curr Gastroenterol Rep 2002 Oct; 4(5): 383-91.
  • 26. Sampimon D, Kolesny I, Korte M et al.: Use of Angiotensin II Inhibitors in Patients That Develop Encapsulating Peritoneal Sclerosis. Perit Dial Int 2010; 30: 656-59.
Typ dokumentu
Bibliografia
Identyfikatory
Identyfikator YADDA
bwmeta1.element.-psjd-doi-10_1515_pjs-2015-0073
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.